Related by context. Frequent words. (Click for all words.) 66 heavily pretreated 66 phase IIa 65 Phase 2a trial 65 Phase Ib clinical 64 pharmacodynamic effects 64 Traficet EN 64 placebo controlled clinical 63 CR# vcMMAE 63 tanespimycin 63 PROMACTA 63 double blinded placebo 63 Stedivaze 63 ponatinib 63 Phase IIa trial 63 Phase 2b study 62 elotuzumab 62 axitinib 62 decitabine 62 mg kg dose 62 randomized Phase III 62 relapsed refractory multiple myeloma 62 Phase 1a 62 glatiramer acetate 62 dose escalation trial 61 dose cohorts 61 CoFactor 61 dose escalation 61 Phase 1b trial 61 BAY #-# 61 RRMS patients 61 PRISTIQ 61 TELCYTA 61 Secondary endpoints include 61 NLX P# 60 noninferiority 60 mRCC 60 Pivotal Phase III 60 CCX# 60 Phenoptin 60 Phase 2b trial 60 mg QD 60 ONTAK 60 Pivotal Trial 60 multicenter clinical 60 IMC A# 60 Gabapentin GR 60 PXD# 60 Phase 2a clinical 60 COPAXONE R 60 Phase Ia 60 phase IIb 60 phase 2a 60 Cloretazine R VNP#M 60 GSK# [001] 59 secondary efficacy endpoints 59 PRECiSE 59 superficial bladder cancer 59 mucosal healing 59 Azedra 59 registrational 59 DAVANAT 59 seroprotection 59 vandetanib 59 INTEGRILIN 59 subgroup analyzes 59 AZOR 59 confirmatory Phase III 59 alvimopan 59 mcg dose 59 registrational trial 59 Asentar 59 Phase III Clinical Trial 59 HSCT 59 unblinding 59 irbesartan 59 figitumumab 59 dose limiting toxicities 59 Phase 1b clinical 59 IMGN# 59 Fidaxomicin 59 IIa clinical trial 59 eniluracil 59 blinatumomab 59 Amrubicin 59 pharmacokinetic profiles 59 dose titration 59 HGS ETR1 59 carotid artery stenting 59 APOPTONE 59 Pivotal Phase 59 OncoVEX GM CSF 58 placebo controlled Phase 58 MIRCERA 58 abiraterone acetate 58 ZD# [001] 58 KRN# 58 intravesical 58 vicriviroc 58 administered subcutaneously 58 teduglutide 58 SPIRIT III